Adriano. Guetg, et.al., Essential amino acid transporter Lat4 (Slc43a2) is required for mouse development., The Journal of physiology, 2015, 593

http://rdf.ncbi.nlm.nih.gov/pubmed/25480797

Adriano. Guetg, et.al., Essential amino acid transporter Lat4 (Slc43a2) is required for mouse development., The Journal of physiology, 2015, 593

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased fasted circulating glucose level_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0013278I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• abnormal liver physiology_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0000609I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• abnormal amino acid level_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0005332I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• increased fatty acid level_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0005281I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• slow postnatal weight gain_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0008489I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• abnormal circulating glucose level_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0000188I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• abnormal intestinal absorption_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0001666I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• abnormal placental transport_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0004265I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• abnormal amniotic fluid composition_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0012172I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• liver inflammation_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0001860I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• fetal growth retardation_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0004201I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• abnormal circulating amino acid level_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0005311I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• decreased fetal weight_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0009431I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• increased circulating carnitine level_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0003979I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd
• postnatal lethality, complete penetrance_Slc43a2<Gt(258C1)Cmhd>/Slc43a2<Gt(258C1)Cmhd>
  http://metadb.riken.jp/0011085I129S1Sv129X1SvJC57BL6CD1Slc43a2Gt258C1CmhdSlc43a2Gt258C1CmhdSlc43a2Gt258C1Cmhd